6572 Federal Register / Vol. 89, No. 22 / Thursday, February 1, 2024 / Notices 

dialing the phone number (1–833–558– 

0712) and entering the meeting number/ 

access code (2761 198 6545). 

Written comments from members of 

the public must be sent to Tiffin RossShepard, Designated Federal Officer, 

HSRD, Department of Veterans Affairs 

(14RDH), 810 Vermont Avenue NW, 

Washington, DC 20420, or to 

Tiffin.Ross-Shepard@va.gov at least five 

days before the meeting. The public 

comments will be shared with the Board 

members. The public may not attend the 

closed portion of the meeting, as 

disclosure of research information could 

significantly obstruct implementation of 

proposed agency action regarding the 

research proposals. As provided by 

Public Law 92–463 subsection 10(d), 

and amended by Public Law 94–409, 

closing the committee meeting is in 

accordance with title 5 U.S.C. 552b(c)(6) 

and (9)(B). 

Dated: January 29, 2024. 

LaTonya L. Small, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2024–02006 Filed 1–31–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF VETERANS 

AFFAIRS 

Rehabilitation Research and 

Development Service Scientific Merit 

Review Board; Federal Register Notice 

of Meeting 

The Department of Veterans Affairs 

(VA) gives notice under the Federal 

Advisory Committee Act, 5 U.S.C. ch. 

10, that a meeting of the Rehabilitation 

Research and Development Service 

(RR&D) Scientific Merit Review Board 

(hereinafter, ‘‘the Board’’) will be held 

on Wednesday, March 6, 2024, via 

Webex from 1–1:30 p.m. EST. The 

meeting will be partially closed to the 

public, with an open portion from 1– 

1:10. The closed portion, from 1:10–1:30 

p.m., will be used for discussion, 

examination of and reference to the 

research applications and scientific 

review. Discussions will involve 

reference to staff and consultant 

critiques of research proposals. 

Discussions will also cover the scientific 

merit of each proposal and the 

qualifications of personnel conducting 

the studies, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Additionally, premature disclosure of 

research information could significantly 

obstruct implementation of proposed 

agency action regarding the research 

proposals. As provided by Public Law 

92–463 subsection 10(d), and amended 

by Public Law 94–409, closing the 

committee meeting is in accordance 

with 5 U.S.C. 552b(c)(6) and (9)(B). 

The objective of the Board is to 

provide for the fair and equitable 

selection of the most meritorious 

research projects for support by VA 

research funds and to offer advice for 

research program officials on program 

priorities and policies. The ultimate 

objective of the Board is to ensure that 

the VA RR&D program promotes 

functional independence and improves 

the quality of life for impaired and 

disabled Veterans. 

Board members will advise the 

Director of RR&D and the Chief 

Research and Development Officer on 

the scientific and technical merit, 

mission relevance and protection of 

human and animal subjects of the 

proposals submitted to RR&D. The 

Board does not consider grants, 

contracts or other forms of extramural 

research. 

Members of the public may attend the 

open portion of the meeting via WebEx, 

from 1–1:10 p.m., in listen-only mode, 

as the time-limited open agenda does 

not allow for public comment 

presentations. To attend the open 

portion of the meeting, the public may 

dial the Webex phone number (1–833– 

558–0712), then enter the meeting 

access code (2764 419 8398). 

Written comments from members of 

the public should be mailed to Kristy 

Benton-Grover, Designated Federal 

Officer, RR&D, Department of Veterans 

Affairs (14RDR), 810 Vermont Avenue 

NW, Washington, DC 20420, or to 

Kristy.Benton-Grover@va.gov at least 

five days before the meeting. The public 

comments will be shared with the Board 

members. The public may not attend the 

closed portion of the meeting as 

disclosure of research information could 

significantly obstruct implementation of 

proposed agency action regarding the 

research proposals. As provided by 

Public Law 92–463 subsection 10(d), 

and amended by Public Law 94–409, 

closing the committee meeting is in 

accordance with title 5 U.S.C. 552b(c)(6) 

and (9)(B). 

Dated: January 29, 2024. 

LaTonya L. Small, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2024–02002 Filed 1–31–24; 8:45 am] 

BILLING CODE 8320–01–P 


ddrumheller on DSK120RN23PROD with NOTICES1